Industry
Medical - Devices
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 06, 2024 | 9:11 pm
Portfolio Pulse from Benzinga Newsdesk
August 06, 2024 | 8:35 pm
Portfolio Pulse from Benzinga Newsdesk
May 22, 2024 | 12:08 pm
Portfolio Pulse from Avi Kapoor
May 08, 2024 | 5:38 pm
Portfolio Pulse from Benzinga Newsdesk
May 08, 2024 | 5:18 pm
Portfolio Pulse from Benzinga Insights
May 08, 2024 | 4:31 pm
Portfolio Pulse from Avi Kapoor
May 08, 2024 | 3:11 pm
Portfolio Pulse from Benzinga Newsdesk
May 07, 2024 | 9:24 pm
Portfolio Pulse from Benzinga Newsdesk
May 07, 2024 | 8:44 pm
Portfolio Pulse from Benzinga Newsdesk
April 23, 2024 | 3:22 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.